Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

We haven't written up this one. MarketWatch Top has the full story — the link below goes straight to it.

Read the original at marketwatch.com →

More in Finance & Markets

More from Thursday 27 August →